🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next week, we will announce our second quarter 2024 earnings and provide a corporate update. For more information, visit: ir.tayshagtx.com/news-releases/…

Today, we reported our second quarter 2024 earnings and provided a corporate update. Read the release: ir.tayshagtx.com/news-releases/…

We’re pleased to share our President and Head of R&D will be participating in a panel focused on “How Investors See the Rare Space Now” on October 22 at the #NORDsummit. See below for additional details and information on how to register to attend.

We're pleased to present previously disclosed clinical data from our ongoing REVEAL Phase 1/2 adolescent/adult trial and our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome at the upcoming #WorldRettSyndromeCongress. ir.tayshagtx.com/news-releases/…

It's #RettSyndromeAwarenessMonth and we’re pleased to help raise awareness and support the patients and families living with #Rettsyndrome as we continue on our mission to bring a #genetherapy to the Rett syndrome community.

We look forward to presenting biodistribution data evaluating AAV9 #genetherapy delivery across five non-human primate studies at the #ESGCT2024 Annual Congress. Learn more about the upcoming presentation: ir.tayshagtx.com/news-releases/…

In recognition of #RettSyndromeAwarenessMonth, we gathered for a viewing of Magnolia’s Hope, a documentary following the Tesler family’s journey with #RettSyndrome. Thank you AJ Tesler and Magnolia’s Hope Documentary for your continued dedication to raising awareness of Rett syndrome!

Taysha is pleased to support International Rett Syndrome Foundation’s Strollathon events to help fundraise, advocate and accelerate research for #Rettsyndrome. Learn more: all-in.rettsyndrome.org #RettSyndromeAwarenessMonth

Next week, we will announce our third quarter 2024 earnings and provide a corporate update. For more information, visit: ir.tayshagtx.com/news-releases/…

Today, we reported our third quarter 2024 earnings and provided a corporate update. Read the release: ir.tayshagtx.com/news-releases/…

Next week, we will announce our full-year 2024 earnings and provide a corporate update. For more information, visit: ir.tayshagtx.com/news-releases/…

The countdown to #RareDiseaseDay is on! The #TayshaTeam is proud to support the global initiative to raise awareness and generate support for those on a rare medical journey. Learn more about Rare Disease Day and how to get involved by visiting rarediseaseday.org.

Today, we announced our full-year 2024 earnings and provided a corporate update. Learn more: ir.tayshagtx.com/news-releases/…

On #RareDiseaseDay, we heard from two #TayshaTeam members who shared their personal connection to #Rettsyndrome, a rare neurodevelopmental disease, and discussed the importance of raising awareness for individuals, families & caregivers impacted by rare diseases. #ShowYourStripes

We're a proud sponsor of International Rett Syndrome Foundation's new learning experience where families can learn more about #RettSyndrome research, clinical trials, and the future of #genetherapy. Congratulations to #IRSF on the launch of this exciting and educational program!

Congrats to Laura Sepp-Lorenzino, PhD, and Steven Gray, PhD, on their election to ASGCT's Board of Directors! We’re thrilled to see them share their expertise to help advance genetic and cellular therapies. asgct.org/publications/n…

Next week, we will announce our first quarter 2025 earnings and provide a corporate update. For more information, visit: ir.tayshagtx.com/news-releases/…

Today, we reported our first quarter 2025 earnings and provided a corporate update. Read the release: ir.tayshagtx.com/news-releases/… #genetherapy #Rettsyndrome

We’re pleased to share key elements of our pivotal Part B trial design for TSHA-102 in #Rettsyndrome, enabled by International Rett Syndrome Foundation’s natural history dataset, and positive clinical data from Part A of our REVEAL Phase 1/2 trials evaluating TSHA-102. Learn more: ir.tayshagtx.com/news-releases/…

We’re thrilled to announce details for our upcoming oral presentations at the @rettsyndrome 2025 International Rett Syndrome Foundation (RSF) Rett Syndrome Scientific Meeting! Learn more about our presentations here: ir.tayshagtx.com/news-releases/…